US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 1.440
  • -0.450-23.81%
Close Dec 13 16:00 ET
  • 1.450
  • +0.010+0.69%
Post 20:01 ET
118.87MMarket Cap-0.57P/E (TTM)

Editas Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-48.31%-52.59M
-47.41%-57.06M
-39.43%-49.87M
25.47%-132.18M
47.39%-22.24M
26.13%-35.46M
-2.29%-38.71M
27.34%-35.77M
-8.27%-177.35M
-22.24%-42.27M
Net income from continuing operations
-38.03%-62.14M
-67.80%-67.61M
-26.34%-61.95M
30.49%-153.22M
68.93%-18.87M
19.21%-45.02M
24.63%-40.29M
2.93%-49.04M
-14.51%-220.43M
-46.58%-60.74M
Operating gains losses
----
----
----
----
----
--0
--0
--1.58M
----
----
Depreciation and amortization
5.61%1.6M
-7.79%1.42M
-8.74%1.41M
-4.31%6.06M
-7.04%1.47M
-5.61%1.51M
-3.63%1.54M
-0.90%1.54M
25.41%6.34M
4.37%1.58M
Other non cash items
--0
----
----
--1.6M
----
----
----
----
----
----
Change In working capital
-4.89%4.34M
245.81%6.41M
-24.13%4.8M
-119.50%-1.59M
-167.27%-8.09M
777.31%4.56M
-158.08%-4.4M
153.01%6.33M
138.19%8.18M
555.55%12.02M
-Change in receivables
186.76%118K
100.05%1K
102.77%9.94M
-3.36%-5.04M
-54.53%-7.77M
-122.93%-136K
-410.17%-2.04M
543.71%4.9M
-184.38%-4.88M
-31,306.25%-5.03M
-Change in prepaid assets
570.00%1.07M
326.19%2.14M
-203.15%-1.61M
-43.80%-197K
-118.02%-968K
-86.83%160K
-17.06%-947K
1,673.74%1.56M
-103.67%-137K
-119.16%-444K
-Change in payables and accrued expense
-105.04%-239K
179.78%3.58M
-577.01%-4.15M
-82.37%2.62M
-89.05%1.5M
1,119.35%4.74M
-176.49%-4.49M
120.66%870K
380.36%14.87M
92.41%13.68M
-Change in other current assets
72.19%4.09M
-237.36%-4.17M
-76.95%1.34M
141.67%6.63M
75.70%-4.58M
227.17%2.37M
17.69%3.03M
162.51%5.8M
-309.90%-15.92M
-830.19%-18.84M
-Change in other current liabilities
72.89%-698K
10,012.50%4.85M
89.38%-723K
-131.93%-5.61M
-83.55%3.73M
-346.88%-2.58M
101.65%48K
-111.76%-6.81M
267.41%17.57M
786.66%22.65M
-Change in other working capital
----
----
----
----
----
----
----
----
85.32%-3.33M
--0
Cash from discontinued investing activities
Operating cash flow
-48.31%-52.59M
-47.41%-57.06M
-39.43%-49.87M
25.47%-132.18M
47.39%-22.24M
26.13%-35.46M
-2.29%-38.71M
27.34%-35.77M
-8.27%-177.35M
-22.24%-42.27M
Investing cash flow
Cash flow from continuing investing activities
181.68%83.98M
300.20%51.95M
-120.39%-4.75M
-103.27%-3.73M
328.28%62.84M
-215.23%-102.82M
424.39%12.98M
-58.73%23.27M
309.43%114.07M
-20.53%-27.53M
Net PPE purchase and sale
-1,122.18%-2.92M
-162.12%-3.49M
-1.68%-1.87M
-15.10%-4.72M
-109.46%-1.31M
61.07%-239K
-117.10%-1.33M
18.15%-1.84M
48.60%-4.1M
78.07%-624K
Net investment purchase and sale
184.71%86.9M
287.34%55.45M
-111.45%-2.87M
-99.16%988K
338.43%64.15M
-214.18%-102.58M
522.52%14.32M
-57.17%25.11M
354.18%118.17M
-34.55%-26.9M
Cash from discontinued investing activities
Investing cash flow
181.68%83.98M
300.20%51.95M
-120.39%-4.75M
-103.27%-3.73M
328.28%62.84M
-215.23%-102.82M
424.39%12.98M
-58.73%23.27M
309.43%114.07M
-20.53%-27.53M
Financing cash flow
Cash flow from continuing financing activities
0
-99.73%322K
192K
9,093.07%118.04M
-16.96%514K
0
31,923.16%117.53M
0
-99.54%1.28M
-41.44%619K
Net common stock issuance
--0
----
----
--117.08M
--0
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
-27.80%322K
--192K
-25.23%960K
-16.96%514K
--0
21.53%446K
--0
-96.07%1.28M
-41.38%619K
Cash from discontinued financing activities
Financing cash flow
--0
-99.73%322K
--192K
9,093.07%118.04M
-16.96%514K
--0
31,923.16%117.53M
--0
-99.54%1.28M
-41.44%619K
Net cash flow
Beginning cash position
-69.60%68.32M
-44.99%73.1M
-12.29%127.53M
-29.89%145.4M
-59.73%86.42M
29.67%224.69M
-38.12%132.9M
-29.89%145.4M
44.47%207.4M
-18.65%214.58M
Current changes in cash
122.70%31.39M
-105.21%-4.79M
-335.37%-54.43M
71.18%-17.87M
159.43%41.11M
-434.79%-138.28M
321.30%91.8M
-269.80%-12.5M
-197.12%-62M
-22.74%-69.18M
End cash Position
15.38%99.71M
-69.60%68.32M
-44.99%73.1M
-12.29%127.53M
-12.29%127.53M
-59.73%86.42M
29.67%224.69M
-38.12%132.9M
-29.89%145.4M
-29.89%145.4M
Free cash flow
-55.50%-55.51M
-51.22%-60.56M
-37.59%-51.74M
24.56%-136.9M
45.11%-23.55M
26.57%-35.7M
-4.07%-40.04M
26.94%-37.61M
-5.64%-181.47M
-14.62%-42.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -48.31%-52.59M-47.41%-57.06M-39.43%-49.87M25.47%-132.18M47.39%-22.24M26.13%-35.46M-2.29%-38.71M27.34%-35.77M-8.27%-177.35M-22.24%-42.27M
Net income from continuing operations -38.03%-62.14M-67.80%-67.61M-26.34%-61.95M30.49%-153.22M68.93%-18.87M19.21%-45.02M24.63%-40.29M2.93%-49.04M-14.51%-220.43M-46.58%-60.74M
Operating gains losses ----------------------0--0--1.58M--------
Depreciation and amortization 5.61%1.6M-7.79%1.42M-8.74%1.41M-4.31%6.06M-7.04%1.47M-5.61%1.51M-3.63%1.54M-0.90%1.54M25.41%6.34M4.37%1.58M
Other non cash items --0----------1.6M------------------------
Change In working capital -4.89%4.34M245.81%6.41M-24.13%4.8M-119.50%-1.59M-167.27%-8.09M777.31%4.56M-158.08%-4.4M153.01%6.33M138.19%8.18M555.55%12.02M
-Change in receivables 186.76%118K100.05%1K102.77%9.94M-3.36%-5.04M-54.53%-7.77M-122.93%-136K-410.17%-2.04M543.71%4.9M-184.38%-4.88M-31,306.25%-5.03M
-Change in prepaid assets 570.00%1.07M326.19%2.14M-203.15%-1.61M-43.80%-197K-118.02%-968K-86.83%160K-17.06%-947K1,673.74%1.56M-103.67%-137K-119.16%-444K
-Change in payables and accrued expense -105.04%-239K179.78%3.58M-577.01%-4.15M-82.37%2.62M-89.05%1.5M1,119.35%4.74M-176.49%-4.49M120.66%870K380.36%14.87M92.41%13.68M
-Change in other current assets 72.19%4.09M-237.36%-4.17M-76.95%1.34M141.67%6.63M75.70%-4.58M227.17%2.37M17.69%3.03M162.51%5.8M-309.90%-15.92M-830.19%-18.84M
-Change in other current liabilities 72.89%-698K10,012.50%4.85M89.38%-723K-131.93%-5.61M-83.55%3.73M-346.88%-2.58M101.65%48K-111.76%-6.81M267.41%17.57M786.66%22.65M
-Change in other working capital --------------------------------85.32%-3.33M--0
Cash from discontinued investing activities
Operating cash flow -48.31%-52.59M-47.41%-57.06M-39.43%-49.87M25.47%-132.18M47.39%-22.24M26.13%-35.46M-2.29%-38.71M27.34%-35.77M-8.27%-177.35M-22.24%-42.27M
Investing cash flow
Cash flow from continuing investing activities 181.68%83.98M300.20%51.95M-120.39%-4.75M-103.27%-3.73M328.28%62.84M-215.23%-102.82M424.39%12.98M-58.73%23.27M309.43%114.07M-20.53%-27.53M
Net PPE purchase and sale -1,122.18%-2.92M-162.12%-3.49M-1.68%-1.87M-15.10%-4.72M-109.46%-1.31M61.07%-239K-117.10%-1.33M18.15%-1.84M48.60%-4.1M78.07%-624K
Net investment purchase and sale 184.71%86.9M287.34%55.45M-111.45%-2.87M-99.16%988K338.43%64.15M-214.18%-102.58M522.52%14.32M-57.17%25.11M354.18%118.17M-34.55%-26.9M
Cash from discontinued investing activities
Investing cash flow 181.68%83.98M300.20%51.95M-120.39%-4.75M-103.27%-3.73M328.28%62.84M-215.23%-102.82M424.39%12.98M-58.73%23.27M309.43%114.07M-20.53%-27.53M
Financing cash flow
Cash flow from continuing financing activities 0-99.73%322K192K9,093.07%118.04M-16.96%514K031,923.16%117.53M0-99.54%1.28M-41.44%619K
Net common stock issuance --0----------117.08M--0--0----------0--0
Proceeds from stock option exercised by employees --0-27.80%322K--192K-25.23%960K-16.96%514K--021.53%446K--0-96.07%1.28M-41.38%619K
Cash from discontinued financing activities
Financing cash flow --0-99.73%322K--192K9,093.07%118.04M-16.96%514K--031,923.16%117.53M--0-99.54%1.28M-41.44%619K
Net cash flow
Beginning cash position -69.60%68.32M-44.99%73.1M-12.29%127.53M-29.89%145.4M-59.73%86.42M29.67%224.69M-38.12%132.9M-29.89%145.4M44.47%207.4M-18.65%214.58M
Current changes in cash 122.70%31.39M-105.21%-4.79M-335.37%-54.43M71.18%-17.87M159.43%41.11M-434.79%-138.28M321.30%91.8M-269.80%-12.5M-197.12%-62M-22.74%-69.18M
End cash Position 15.38%99.71M-69.60%68.32M-44.99%73.1M-12.29%127.53M-12.29%127.53M-59.73%86.42M29.67%224.69M-38.12%132.9M-29.89%145.4M-29.89%145.4M
Free cash flow -55.50%-55.51M-51.22%-60.56M-37.59%-51.74M24.56%-136.9M45.11%-23.55M26.57%-35.7M-4.07%-40.04M26.94%-37.61M-5.64%-181.47M-14.62%-42.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List

Investment Theme Gene Editing
Gene Editing
Intraday-0.48%